Augmedix, Inc. (AUGX)

Market Cap	116.16M
Revenue (ttm)	51.58M
Net Income (ttm)	-23.85M
Shares Out	49.43M
EPS (ttm)	-0.47
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	23,983
Open	2.340
Previous Close	2.350
Day's Range	2.340 - 2.350
52-Week Range	0.730 - 6.250
Beta	-0.19
Analysts	Buy
Price Target	5.25 (+123.4%)
Earnings Date	Nov 4, 2024

About AUGX

Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient’s health record; and Augmedix Go, an autonomous, ambient AI mobile software applicatio...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2013
• Employees: 1,430
• Stock Exchange: NASDAQ
• Ticker Symbol: AUGX
• Website: https://www.augmedix.com

Financial Performance

In 2023, Augmedix's revenue was $44.86 million, an increase of 45.01% compared to the previous year's $30.93 million. Losses were -$19.17 million, -21.59% less than in 2022.

Analyst Forecast

According to 4 analysts, the average rating for AUGX stock is "Buy." The 12-month stock price forecast is $5.25, which is an increase of 123.40% from the latest price.

Price Target

$5.25

(123.40% upside)

Analyst Consensus: Buy